Hiscox has led CoverHound’s series D round, which also attracted Chubb, Aflac and MS&AD, bringing the insurance comparison platform’s overall funding to more than $112m.
Month: February 2019
SoftBank studies 10-figure Latin America fund
SoftBank is reportedly considering a Latin American fund that would be sized in the billions of dollars, in addition to leading a $149m round for Brazil-based Gympass.
Western Digital finds Komprise in $24m series C
Digital Western Capital has joined existing investors in a Top Tier Ventures-led round that increased the data management provider’s total funding to $42m.
Whiteaker eyes IBM Ventures role
Thomas Whiteaker, who helped spin out Propel Venture Partners from banking firm BBVA, has gone to IBM Ventures as a partner to oversee fintech investments.
BBG beckons outsiders to new fund
BBG Ventures, which was founded by AOL and is now funded by Verizon Media, is reportedly seeking external commitments for its next fund.
GE Ventures puts resources into Flux
General Electric’s corporate venturing unit is launching a content portal called Flux to help companies overcome barriers to diversity and inclusiveness.
Sosei starts up two new companies
Pharmaceutical company Sosei has launched new companies using technology from its 2015 acquisition of Heptares, both of which have received funding from Medicxi.
Slack officially starts journey to public markets
Slack has confidentially filed for a direct listing that will allow SoftBank Vision Fund, Comcast Ventures and Alphabet unit GV to sell shares.
Microsoft helps Databricks construct $250m series E
The corporate formed a partnership with data analysis technology provider Databricks in 2016 and has now invested, as part of a round that valued it at $2.75bn.
Sustainable Bioproducts sucks in $33m
Corporate venturing vehicles Danone Manifesto Ventures and ADM Ventures both took part in a series A round for the Nasa spinoff, which is developing edible proteins.
TCR² squares range for $80m IPO
6 Dimensions Capital is set to exit immuno-oncology drug developer TCR² Therapeutics in an offering likely to raise between $70m and $80m.
Catalytic processes $30m in series B funding
Intel Capital has now invested a total of $30m in three companies in the past few days, having led data automation software developer Catalytic’s series B round.
Bud pals with corporates to raise $20m
The banking software development platform received series A funding from investors including HSBC and Goldman Sachs, which co-led the round, Banco Sabadell and ANZ.
Mahan moves up at Stanley Ventures
Michael Mahan, a GCV Rising Star in 2018 and former investment manager at Stanley Ventures, has been promoted to managing director of the unit.